Detalhe da pesquisa
1.
Improved nationwide survival of sarcoma patients with a network of reference centers.
Ann Oncol
; 35(4): 351-363, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246351
2.
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)â.
Ann Oncol
; 32(4): 533-541, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482247
3.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Ann Oncol
; 30(7): 1143-1153, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081028
4.
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Int J Gynecol Cancer
; 29(4): 691-698, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772825
5.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 28(12): 3000-3008, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950372
6.
Improved survival using specialized multidisciplinary board in sarcoma patients.
Ann Oncol
; 28(11): 2852-2859, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29117335
7.
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.
Ann Oncol
; 28(8): 1979-1987, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838212
8.
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.
Acta Oncol
; 56(1): 88-92, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838944
9.
High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications.
Ann Oncol
; 32(5): 684-686, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529741
10.
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study.
Ann Oncol
; 26(7): 1465-70, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041763
11.
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 865-872, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070543
12.
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.
Ann Oncol
; 25(3): 578-583, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325833
13.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 30(2): 344, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741569
14.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Ann Oncol
; 30(8): 1407, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168580
15.
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Eur J Cancer
; 196: 113454, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008029
16.
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group.
Br J Cancer
; 109(4): 909-14, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23922114
17.
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival.
Ann Oncol
; 24(7): 1924-1930, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23493135
18.
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Ann Oncol
; 24(4): 1087-93, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175622
19.
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study.
Ann Oncol
; 24(11): 2922-6, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24170610
20.
Advanced chondrosarcomas: role of chemotherapy and survival.
Ann Oncol
; 24(11): 2916-22, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099780